| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/14/2009 | US20090124548 Method of Using Fish Plasma Components to Inhibit Glial Scarring and Promote Functional Recovery in the Mammalian CNS |
| 05/14/2009 | US20090124547 conjugated drug comprising nerve growth factor linked to a steroid; for tissue-targeted therapy; treating pain |
| 05/14/2009 | US20090124546 Antimicrobially Active Peptides |
| 05/14/2009 | US20090124545 Novel nucleic acid encoding a novel protein of candida albicans and uses thereof |
| 05/14/2009 | US20090124544 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| 05/14/2009 | US20090124543 Activity dependent neurotrophic factor iii (adnf iii) |
| 05/14/2009 | US20090124542 Methods and reagents for treatment and diagnosis of age-related macular degeneration |
| 05/14/2009 | US20090124541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseases |
| 05/14/2009 | US20090124540 Anti-adhesion composites and methods of use thereof |
| 05/14/2009 | US20090124539 Methods of treating infection |
| 05/14/2009 | US20090124538 Selective R-cadherin antagonists and methods |
| 05/14/2009 | US20090124537 Screening method for bone morphogenetic mimetics |
| 05/14/2009 | US20090124536 Calcium phosphate/sulfate-based bone implant composition |
| 05/14/2009 | US20090124535 Viscous terpolymers as drug delivery platform |
| 05/14/2009 | US20090124534 Trehalose Click Polymers for Delivery of Biologically Active Molecules |
| 05/14/2009 | US20090124009 Antisense modulation of ptp1b expression |
| 05/14/2009 | US20090123974 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 05/14/2009 | US20090123949 Methods for determining the prognosis for cancer patients using tucan |
| 05/14/2009 | US20090123938 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist |
| 05/14/2009 | US20090123581 Collagen cross-linking agents on dental restorative treatment and preventive dentistry |
| 05/14/2009 | US20090123565 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 05/14/2009 | US20090123556 Sustained release pharmaceutical compositions |
| 05/14/2009 | US20090123555 Stimulateable Polymer Particles Exhibiting Reactive Functions, Method for the Production and the Use Thereof |
| 05/14/2009 | US20090123553 Peptide nanostructures and methods of generating and using the same |
| 05/14/2009 | US20090123551 Gastrointestinal delivery systems |
| 05/14/2009 | US20090123547 Methods and Compositions for Regenerating Connective Tissue |
| 05/14/2009 | US20090123544 Stimulus-responsive biodegradable polymers and methods of preparation |
| 05/14/2009 | US20090123542 oral administered powder mixture comprising a dissolved whey protein to increase release the bioactive carotenoid, polyphenol, vitamins, flavonoid, isoflavone, ceramide |
| 05/14/2009 | US20090123531 Glutathione-based delivery system |
| 05/14/2009 | US20090123530 Liposome Drug Delivery |
| 05/14/2009 | US20090123518 Biodegradable implants with controlled bulk density |
| 05/14/2009 | US20090123516 Drug delivery from implants using self-assembled monolayers-therapeutic sams |
| 05/14/2009 | US20090123511 Biomaterial derived from vertebrate liver tissue |
| 05/14/2009 | US20090123503 Conditioned Cell Culture Medium Compositions and Methods of Use |
| 05/14/2009 | US20090123498 Treatment of post-stroke muscle pain |
| 05/14/2009 | US20090123496 Purification of hbv antigens for use in vaccines |
| 05/14/2009 | US20090123489 Novel immunotherapy against neuronal and brain tumors |
| 05/14/2009 | US20090123486 Vaccine Composition Comprising An Antigen And A Peptide Having Adjuvant Properties |
| 05/14/2009 | US20090123480 Bivalent smac mimetics and the uses thereof |
| 05/14/2009 | US20090123472 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 05/14/2009 | US20090123471 T-Cadherin antigen arrays and uses thereof |
| 05/14/2009 | US20090123469 Anti-factor B antibodies and their uses |
| 05/14/2009 | US20090123468 Transducible polypeptides for modifying metabolism |
| 05/14/2009 | US20090123463 Methods and compositions for inducing apoptosis |
| 05/14/2009 | US20090123462 Fgfr agonists |
| 05/14/2009 | US20090123460 Immunostimulatory combinations |
| 05/14/2009 | US20090123459 Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease |
| 05/14/2009 | US20090123455 Slimming cosmetic composition containing a substance inducing the production of il-6 |
| 05/14/2009 | US20090123454 using collagenase injections to lyse the collagenous adhesions in the shoulder and treat adhesive capsulitis or frozen shoulder |
| 05/14/2009 | US20090123453 Pharmaceutical Preparations And Medicines Capable Of Generating, And/Or Containing, Thrombin |
| 05/14/2009 | US20090123452 Protease screening methods and proteases identified thereby |
| 05/14/2009 | US20090123451 Slow intraventricular delivery |
| 05/14/2009 | US20090123450 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 05/14/2009 | US20090123449 Composition of Biofilm Control Agent |
| 05/14/2009 | US20090123448 Nucleic acid molecules coding for a dextransaccharase catalysing the synthesis of dextran with alpha 1,2 osidic sidechains |
| 05/14/2009 | US20090123447 Compositions and methods to inhibit rna viral reproduction |
| 05/14/2009 | US20090123446 Use of IL-1 Antagonists to Treat Gout |
| 05/14/2009 | US20090123440 using gutless adenovirus vector; gene therapy; gutless means incapable of expressing any adenovirus antigens; atherosclerosis |
| 05/14/2009 | US20090123427 Method of Treating a Malignancy in a Subject and a Pharmaceutical Composition for Use in Same |
| 05/14/2009 | US20090123425 Macrocyclic, pyridazinone-containing hepatitis c serine protease inhibitors |
| 05/14/2009 | US20090123424 Methods of protein purification and recovery |
| 05/14/2009 | US20090123423 Hydroxyamic analogs as hepatitis c virus serine protease inhibitor |
| 05/14/2009 | US20090123422 Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-y |
| 05/14/2009 | US20090123421 Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 05/14/2009 | US20090123420 Regulation of T Cell-Mediated Immunity by D Isomers of Inhibitors of Indoleamine-2,3-Dioxygenase |
| 05/14/2009 | US20090123419 Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents |
| 05/14/2009 | US20090123418 Methods of administering n-(5-tert-butyl-isoxazol-3-yl)-n'-urea to treat proliferative disease |
| 05/14/2009 | US20090123417 Recombinant super-compound interferon and uses thereof |
| 05/14/2009 | US20090123416 Methods for the treatment of bladder cancer using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione |
| 05/14/2009 | US20090123415 Diagnosis, treatment, and prevention of vascular disorders using il-1 autoantibodies |
| 05/14/2009 | US20090123413 Use of bat monoclonal antibody for immunotherapy |
| 05/14/2009 | US20090123387 Buccal, polar and non-polar spray or capsule containing cardiovascular or reneal drugs |
| 05/14/2009 | US20090123381 Imaging and therapeutic targeting of prostate and bladder tissues |
| 05/14/2009 | US20090123379 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
| 05/14/2009 | US20090123376 Therapeutic agents with decreased toxicity |
| 05/14/2009 | US20090123375 CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration |
| 05/14/2009 | US20090123371 Molecular signature of cancer |
| 05/14/2009 | US20090123370 Alphavbeta6 peptide ligands and their uses |
| 05/14/2009 | US20090123367 Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases |
| 05/14/2009 | DE19638870B4 Tubulysine, Verfahren zu ihrer Gewinnung und sie enthaltende Mittel Tubulysins, process for their production and to compositions comprising |
| 05/14/2009 | DE10163130B4 Apoptotisch wirksame Peptide und diese umfassende pharmazeutische Zusammensetzungen Apoptotic active peptides and pharmaceutical compositions comprising |
| 05/14/2009 | CA2742839A1 Novel neurturin conjugates for pharmaceutical use |
| 05/14/2009 | CA2705105A1 Pharmaceutical composition for cancer treatment |
| 05/14/2009 | CA2705007A1 Compositions and methods for treatment of microbial disorders |
| 05/14/2009 | CA2704974A1 Extracellular histones as biomarkers for prognosis and molecular targets for therapy |
| 05/14/2009 | CA2704746A1 Use of umbilical cord blood in the treatment of premature birth complications |
| 05/14/2009 | CA2704651A1 Use of melanocortins to treat insulin sensitivity |
| 05/14/2009 | CA2704234A1 Modified recombinant factor viii and von willebrand factor and methods of use |
| 05/14/2009 | CA2703099A1 Activin receptor-like kinase-i compositions and methods of use |
| 05/14/2009 | CA2700197A1 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 05/13/2009 | EP2058399A1 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 05/13/2009 | EP2058395A1 Kif-derived peptide capable of binding to hla-a24 molecule |
| 05/13/2009 | EP2058334A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 05/13/2009 | EP2058330A1 Insulin derivative |
| 05/13/2009 | EP2058328A1 Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives |
| 05/13/2009 | EP2058323A1 Tumour-associated peptides which bind to MHC molecules |
| 05/13/2009 | EP2058320A1 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 05/13/2009 | EP2058005A1 Inoculant for treating coeliac disease and method for producing the inoculant, application of a peptide sequence joined with a bacterial toxin for activating the immune system against prolamine and designer peptide |
| 05/13/2009 | EP2057999A2 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 05/13/2009 | EP2057997A1 Preventive and/or therapeutic agent for peripheral neuropathy |